Skip to content

Clinical trials

Completed Phase 2 Anemia, Hemolytic, Autoimmune trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Hemolytic, Autoimmune Phase: Phase 2 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20131
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apellis Pharmaceuticals, Inc.1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Helse Fonna1
Incyte Corporation1
Johns Hopkins University1
Peking Union Medical College Hospital1
University Hospital, Essen1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Hemolytic, Autoimmune8
Hemolysis3
Anemia2
Autoimmune Diseases1
Felty Syndrome1
Hematologic Diseases1
Hereditary Sensory and Autonomic Neuropathies1
Lymphoproliferative Disorders1
Purpura, Thrombocytopenic1
Purpura, Thrombocytopenic, Idiopathic1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.